Malignant neoplasm of temporal lobe
ICD-10 C71.2 is a billable code used to indicate a diagnosis of malignant neoplasm of temporal lobe.
C71.2 refers to a malignant neoplasm located in the temporal lobe of the brain, which is part of the central nervous system (CNS). Tumors in this region can arise from various cell types, including glial cells, neurons, and meningeal tissues. The temporal lobe is crucial for auditory processing, memory, and language comprehension, making tumors in this area particularly impactful on neurological function. Symptoms may include seizures, memory loss, auditory hallucinations, and changes in behavior. Imaging studies such as MRI and CT scans are essential for diagnosis, revealing the tumor's size, location, and potential involvement of surrounding structures. Molecular markers, such as IDH mutations and 1p/19q co-deletion status, can provide prognostic information and guide treatment decisions. Treatment typically involves a multidisciplinary approach, including surgery, radiation therapy, and chemotherapy, depending on the tumor's type and grade. Accurate coding of C71.2 is critical for appropriate reimbursement and tracking of CNS malignancies.
Detailed operative reports, imaging studies, and pathology results.
Surgical resection of temporal lobe tumors, management of post-operative complications.
Ensure accurate coding of surgical procedures and any complications that arise.
Comprehensive treatment plans, including chemotherapy and radiation therapy details.
Management of malignant brain tumors, including adjuvant therapies.
Documenting the rationale for treatment choices based on molecular markers.
Used during surgical intervention for a malignant temporal lobe tumor.
Operative report detailing the procedure and findings.
Neurosurgeons must document the extent of resection and any complications.
MRI and CT scans are essential for diagnosing and coding C71.2, as they provide critical information about the tumor's size, location, and characteristics.
